EMERYVILLE, Calif., Oct. 25,
2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a
leading synthetic biotechnology company accelerating the world's
transition to sustainable consumption through its
Lab-to-Market™ technology platform and clean beauty consumer
brands, today announced a partnership with World Wildlife Fund
(WWF), one of the world's leading conservation organizations, to
support WWF's efforts to improve ocean health and reduce the impact
of fishing on shark populations.
The partnership underlines and furthers Amyris' ESG commitment
as outlined in the company's recently announced and published 2021
Environmental, Social, and Governance ("ESG") report. According to
the most recent Living Planet Report in 2022, the population sizes
of mammals, birds, fish, amphibians and reptiles have seen an
alarming average drop of 69% since 1970. This loss affects human
health and well-being, which is why WWF and Amyris are coming
together to support and protect biodiversity.
During the first year of this partnership, Amyris will support
WWF: (1) to drive fisheries in Ecuador and Peru to more sustainable fishing and (2) to
reduce fishing gear impacts on sharks. Also, Amyris and WWF will
collaborate to identify target ingredients for Amyris' molecule
pipeline that could reduce the impact on ocean ecosystems and have
a meaningful impact on biodiversity and endangered habitats.
"We are thrilled to be partnering with WWF to continue and
deepen our commitment to protecting biodiversity," said
Beth Bannerman, Chief Engagement and
Sustainability Officer, Amyris. "Every day at Amyris we think about
how we can improve the health of people and planet, push boundaries
and drive change, and this partnership is a natural fit."
"As our planet faces a biodiversity crisis, the need for
companies to invest in solutions that protect the health of
essential habitats, including our oceans, has never been more
important," said Sheila Bonini, SVP
Private Sector Engagement, World Wildlife Fund. "We are
enthusiastic about the possibilities this partnership holds for
showing the positive link between sustainability, clean chemistry
and healthy habitats and the importance of science leading to
positive impacts on biodiversity."
About Amyris
Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology company,
transitioning the Clean Health & Beauty and Flavors &
Fragrances markets to sustainable ingredients through fermentation
and the company's proprietary Lab-to-Market™ technology
platform. This Amyris platform leverages state-of-the-art machine
learning, robotics and artificial intelligence, enabling the
company to rapidly bring new innovation to market at commercial
scale. Amyris ingredients are included in over 20,000 products from
the world's top brands, reaching more than 300 million consumers.
Amyris also owns and operates a family of consumer brands that is
constantly evolving to meet the growing demand for sustainable,
effective and accessible products. For more information, please
visit http://www.amyris.com.
Amyris, the Amyris logo, and Lab-to-Market, are trademarks or
registered trademarks of Amyris, Inc. or its subsidiaries in the
U.S. and/or other countries.
Forward-Looking Statements
This release contains forward-looking statements, and any
statements other than statements of historical fact could be deemed
to be forward-looking statements. These forward-looking statements
include, among other things, statements regarding future events,
such as Amyris' commitment to clean, sustainable chemistry in
alignment with its ESG goals and priorities and Amyris'
expectations about how its partnership with WWF could impact ocean
ecosystems and protect biodiversity. These statements are based on
management's current expectations and actual results and future
events may differ materially due to risks and uncertainties,
including risks related to Amyris' liquidity and ability to fund
operating and capital expenses, risks related to its financing
activities, risks related to potential delays or failures in
completing and integrating planned acquisitions, risks related to
potential delays or failures in development, regulatory approval,
launch, production and commercialization of products, risks related
to the COVID-19 pandemic and any other geopolitical events,
including Russia's invasion of
Ukraine, resulting in global
economic, financial and supply chain disruptions that may
negatively impact Amyris' business operations and financial results
or cause market volatility, risks related to Amyris' reliance on
third parties particularly in the supply chain, and other risks
detailed from time to time in filings Amyris makes with the
Securities and Exchange Commission, including Annual Reports on
Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on
Form 8-K. Amyris disclaims any obligation to update information
contained in these forward-looking statements, whether as a
result of new information, future events, or
otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/amyris-and-world-wildlife-fund-announce-partnership-to-protect-biodiversity-301657635.html
SOURCE Amyris, Inc.